Arcus Biosciences Company

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Investors
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Hayward, California, United States
Founded Date:
2015
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
17
Total Funding:
$226.7M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Register and Claim Ownership